1. Overexpression of TIPE2, a Negative Regulator of Innate and Adaptive Immunity, Attenuates Cognitive Deficits in APP/PS1 Mice
- Author
-
Zhihong Yang, Yongzhen Miao, Chuanxia Ju, Lei Wang, Naidong Wang, Ruoyu Zhang, Zihan Xu, Wenjin Shao, and Fang Zhang
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Genetic Vectors ,Immunology ,Neuroscience (miscellaneous) ,Hippocampus ,Mice, Transgenic ,Adaptive Immunity ,Biology ,Injections ,Proinflammatory cytokine ,Pathogenesis ,Amyloid beta-Protein Precursor ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Alzheimer Disease ,Internal medicine ,mental disorders ,Presenilin-1 ,medicine ,Animals ,Immunology and Allergy ,Fear conditioning ,Maze Learning ,Neuroinflammation ,Pharmacology ,Memory Disorders ,Intracellular Signaling Peptides and Proteins ,Wild type ,Gene Expression Regulation, Developmental ,Fear ,Genetic Therapy ,Dependovirus ,Acquired immune system ,Immunity, Innate ,Recombinant Proteins ,Up-Regulation ,Mice, Inbred C57BL ,Disease Models, Animal ,030104 developmental biology ,Endocrinology ,Cytokines ,Tumor necrosis factor alpha ,Cognition Disorders ,030217 neurology & neurosurgery - Abstract
Neuroinflammation plays an early and prominent role in the pathology of Alzheimer's disease (AD). Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) has been identified as a negative regulator of innate and adaptive immunity. However, whether TIPE2 affects cognitive functions in AD-like mouse models remains unknown. In this study, we compared the gene and protein expressions of TIPE2 between the APP/PS1 mice and the age-matched wild type (WT) mice at different stages of development using western blot and RT-qPCR. The hippocampal expression of the TIPE2 mRNA and protein in APP/PS1 mice was higher than that of the WT mice starting from 6 months to 10 months. However, the difference of the TIPE2 expression between the APP/PS1 mice and the WT mice declined in a time-dependent manner. The spatial learning and memory deficit from the 8-month-old APP/PS1 mice was observed in the Y-maze test and fear conditioning task. Interestingly, overexpression of TIPE2 by intra-hippocampal injection of AAV-TIPE2 into APP/PS1 mice resulted in an improvement of learning and memory and reduced expression of inflammatory cytokines, such as TNF-α, IL-6 and IL-1β, and increased expression of anti-inflammatory cytokines, such as IL-10 and Arg-1. Taken together, our findings show that the TIPE2 expression level was negatively correlated with the pathogenesis of Alzheimer's disease, and overexpression of TIPE2 attenuates cognitive deficits in APP/PS1 mice, suggesting TIPE2 is a potential target for pharmacological intervention and improvement of cognitive deficits. Graphical Abstract .
- Published
- 2019
- Full Text
- View/download PDF